



















An evaluation of dose distribution achieved with accerelator-based boron neutron
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研究成果の概要（英文）：Boron neutron capture therapy (BNCT) delivers tumor cell-selective, high LET
 radiation without serious damage to surrounding normal tissue. BNCT possibly be an effective and 
safe treatment option in patients with inoperable locally advanced head and neck cancer. In recent 
years, novel accerelator-based BNCT which can treat patients in hospitals has been developed instead
 of conventional reactor-based BNCT. In this study, the simulation of accerelator-based BNCT with 
developing planning system so-called TSUKUBA plan for accerelator-based BNCT was carried out. It was
 concluded that the developing accerelator-based BNCT planning system could be an accurate and 
useful planning system. 















































































































































た ． Common Terminology Criteria for 


























































 KUR iBNCT (1 mA) 
腫瘍線量(最大, Gy-eq) 41 40.7 
照射時間(分) 61 98 
皮膚線量(最大, Gy-eq) 4.9 8.3 
脳線量(最大, Gy-eq) 6.0 6.1 
右眼線量(最大, Gy-eq) NA 1.7 















 KUR iBNCT (1 mA) 
腫瘍線量(最大, Gy-eq) 37 36.6 
照射時間(分) 60 86 
皮膚線量(最大, Gy-eq) 9.2 7.8 
脳線量(最大, Gy-eq) 7.1 6.0 
右眼線量(最大, Gy-eq) 3.4 3.7 














 KUR iBNCT (1 mA) 
腫瘍線量(最大, Gy-eq) 32 32 
照射時間(分) 75 100 
皮膚線量(最大, Gy-eq) 8.9 9.4 
脳線量(最大, Gy-eq) 4.1 5.0 
右眼線量(最大, Gy-eq) 5.7 5.7 















 KUR iBNCT (1 mA) 
腫瘍線量(最大, Gy-eq) 29 28.9 
照射時間(分) 77 95 
皮膚線量(最大, Gy-eq) 9.4 7.0 
脳線量(最大, Gy-eq) 5.3 4.6 
右眼線量(最大, Gy-eq) 3.7 3.3 
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